Fumihiko Yasui

1.6k citations

37 papers · 1.1k indexed · h-index 16

Virology top 5%
Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 12
- COVID-19 Clinical Research Studies 5
Hepatology top 5%
- Hepatitis C virus research 5
Immunology top 10%
- Immunotherapy and Immune Responses 6
Animal Science and Zoology top 5%
- Animal Virus Infections Studies 9
Epidemiology
- Influenza Virus Research Studies 9
- Respiratory viral infections research 6
- Hepatitis B Virus Studies 5

Co-authors: Michinori Kohara Seiichi Matsugo Kouji Matsushima Kouichi Morita Takuya Umehara Masahiro Kitabatake Misako Yoneda Chieko Kai
Cited by: Virology Infectious Diseases Hepatology
Partner nations: Japan United States China

In The Last Decade

Fumihiko Yasui

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by Fumihiko Yasui

Since Specialization

Citations

This map shows the geographic impact of Fumihiko Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihiko Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihiko Yasui more than expected).

Fields of papers citing papers by Fumihiko Yasui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihiko Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihiko Yasui. The network helps show where Fumihiko Yasui may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fumihiko Yasui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fumihiko Yasui Line = papers co-authored together Fumihiko Yasui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunogenicity of an Intranasal Dual (Core and Surface)-Antigen Vaccine Against Hepatitis B Virus Enhanced by Carboxyl-Vinyl Polymer Excipients Md Haroon Or Rashid,Fumihiko Yasui,Takahiro Sanada,Risa Kono,Tomoko Honda,Bouchra Kitab,Lipi Akter,Masashi Utsunomiya,Risa Sato,Osamu Yoshida,Yoichi Hiasa,Yasunori Oda,Yasumasa Goh,Takashi Miyazaki,Michinori Kohara,Kyoko Tsukiyama–Kohara	2025	0
2	Single Dose of Attenuated Vaccinia Viruses Expressing H5 Hemagglutinin Affords Rapid and Long-Term Protection Against Lethal Infection with Highly Pathogenic Avian Influenza A H5N1 Virus in Mice and Monkeys Fumihiko Yasui,Keisuke Munekata,Tomoko Fujiyuki,Takeshi Kuraishi,Kenzaburo Yamaji,Tomoko Honda,Sumiko Gomi,Misako Yoneda,Takahiro Sanada,Koji Ishii,Yoshihiro Sakoda,Hiroshi Kida,Shôsaku Hattori,Chieko Kai,Michinori Kohara	2025	1
3	Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity Saed Abbasi,Miki Matsui-Masai,Fumihiko Yasui,Akimasa Hayashi,Theofilus A. Tockary,Yuki Mochida,Shiro Akinaga,Michinori Kohara,Kazunori Kataoka,Satoshi Uchida	2024	27
4	Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study Naoya Otsubo,Tatsuya Fukuda,Hiroko Beppu,Chisato Maki,Fumihiko Yasui,Tomohide Hanawa,Chise Sugita,Masanori Murakami,Tetsuya Yamada,Michinori Kohara,Sachiko Wakai	2023	3
5	TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice Liang Cheng,Guangming Li,Caroline Marnata Pellegry,Fumihiko Yasui,Feng Li,Sandra Zurawski,Gérard Zurawski,Yves Lévy,Jenny P.‐Y. Ting,Lishan Su	2021	9
6	Cell-penetrating peptide-mediated cell entry of H5N1 highly pathogenic avian influenza virus Naoki Kajiwara,Namiko Nomura,Masako Ukaji,Naoki Yamamoto,Michinori Kohara,Fumihiko Yasui,Yoshihiro Sakoda,Hiroshi Kida,Futoshi Shibasaki	2020	7
7	Avian H5N1 influenza virus infection causes severe pneumonia in the Northern tree shrew (Tupaia belangeri) Takahiro Sanada,Fumihiko Yasui,Tomoko Honda,Mohammad Enamul Hoque Kayesh,Junichiro Takano,Yumiko Shiogama,Yasuhiro Yasutomi,Kyoko Tsukiyama–Kohara,Michinori Kohara	2019	19
8	Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys Tomoko Fujiyuki,Ryo Horie,Misako Yoneda,Takeshi Kuraishi,Fumihiko Yasui,Hyun-jeong Kwon,Keisuke Munekata,Fusako Ikeda,Miho Hoshi,Yuri Kiso,Mio Omi,Hiroki Sato,Hiroshi Kida,Shôsaku Hattori,Michinori Kohara,Chieko Kai	2017	7
9	Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs Liang Cheng,Jianping Ma,Jingyun Li,Dan Li,Guangming Li,Feng Li,Qing Zhang,Haisheng Yu,Fumihiko Yasui,Chaobaihui Ye,Li-Chung Tsao,Zhiyuan Hu,Lishan Su,Liguo Zhang	2016	134
10	Studying HBV Infection and Therapy in Immune-Deficient NOD-Rag1−/−IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (Fah) Knockout Mice Transplanted with Human Hepatocytes Feng Li,Kouki Nio,Fumihiko Yasui,Christopher M. Murphy,Lishan Su	2016	8
11	Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus Fumihiko Yasui,Michinori Kohara,Masahiro Kitabatake,Tetsu Nishiwaki,Hideki Fujii,Chise Tateno,Misako Yoneda,Kouichi Morita,Kouji Matsushima,Shigeo Koyasu,Chieko Kai	2014	62
12	Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver Satoshi Sekiguchi,Kiminori Kimura,Tomoko Chiyo,Takahiro Ohtsuki,Yoshimi Tobita,Yuko Tokunaga,Fumihiko Yasui,Kyoko Tsukiyama–Kohara,Takaji Wakita,Toshiyuki Tanaka,Masayuki Miyasaka,Kyosuke Mizuno,Yukiko Hayashi,Tsunekazu Hishima,Kouji Matsushima,Michinori Kohara	2012	18
13	PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection Qiang Wang,Shijian Zhang,Hongbing Jiang,Jinlan Wang,Leiyun Weng,Yingying Mao,Satoshi Sekiguchi,Fumihiko Yasui,Michinori Kohara,Philippe Buchy,Vincent Deubel,Ke Xu,Bing Sun,Tetsuya Toyoda	2012	8
14	Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV Fumihiko Yasui,Chieko Kai,Masahiro Kitabatake,Shingo Inoue,Misako Yoneda,Shoji Yokochi,Ryoichi Kase,Satoshi Sekiguchi,Kouichi Morita,Tsunekazu Hishima,Hidenori Suzuki,Katsuo Karamatsu,Yasuhiro Yasutomi,Hisatoshi Shida,Minoru Kidokoro,Kyosuke Mizuno,Kouji Matsushima,Michinori Kohara	2008	187
15	Evaluation of a cyclophilin inhibitor in hepatitis C virus–infected chimeric mice in vivo† Kazuaki Inoue,Takuya Umehara,Urs T. Rüegg,Fumihiko Yasui,Tsunamasa Watanabe,Hiroshi Yasuda,Jean‐Maurice Dumont,Piétro Scalfaro,Makoto Yoshiba,Michinori Kohara	2007	73
16	Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model Takuya Umehara,Masayuki Sudoh,Fumihiko Yasui,Chiho Matsuda,Yukiko Hayashi,Kazuaki Chayama,Michinori Kohara	2006	62
17	Generation of a novel fluorescent product, monochlorofluorescein from dichlorofluorescin by photo-irradiation^† Seiichi Matsugo,Masaaki Sasai,Hideyuki Shinmori,Fumihiko Yasui,Minoru Takeuchi,Tōru Takeuchi	2006	6
18	Brain lipid hydroperoxide level increases in senescence-accelerated mice at an early age Fumihiko Yasui,Masaru Ishibashi,Seiichi Matsugo,Shosuke Kojo,Yutaka Oomura,Kazuo Sasaki	2003	43
19	Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice Fumihiko Yasui,Seiichi Matsugo,Masaru Ishibashi,Takahiro Kajita,Yoshiharu Ezashi,Yutaka Oomura,Shosuke Kojo,Kazuo Sasaki	2002	61
20	The lactate-dependent enhancement of hydroxyl radical generation by the Fenton reaction M. Aktar Ali,Fumihiko Yasui,Seiichi Matsugo,Tetsuya Konishi	2000	46

About Fumihiko Yasui

Fumihiko Yasui is a scholar working on Animal Science and Zoology, Virology and Infectious Diseases, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), Influenza Virus Research Studies (9 papers), Animal Virus Infections Studies (9 papers), Respiratory viral infections research (6 papers), Immunotherapy and Immune Responses (6 papers), COVID-19 Clinical Research Studies (5 papers), Hepatitis B Virus Studies (5 papers) and Hepatitis C virus research (5 papers). The work is most often cited by research in Virology (152 citations), Infectious Diseases (428 citations) and Hepatology (144 citations). Fumihiko Yasui has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Michinori Kohara, Seiichi Matsugo, Kouji Matsushima, Kouichi Morita, Takuya Umehara, Masahiro Kitabatake, Misako Yoneda, Chieko Kai, Masaru Ishibashi and Kazuo Sasaki.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact